Urinary incontinence in women

Y Aoki, HW Brown, L Brubaker, JN Cornu… - Nature reviews Disease …, 2017 - nature.com
Urinary incontinence symptoms are highly prevalent among women, have a substantial
effect on health-related quality of life and are associated with considerable personal and …

The cognitive effect of anticholinergics for patients with overactive bladder

B Welk, K Richardson, JN Panicker - Nature Reviews Urology, 2021 - nature.com
Overactive bladder (OAB) is often treated with medications that block the cholinergic
receptors in the bladder (known as anticholinergics). The effect of this medication class on …

EAU guidelines on assessment and nonsurgical management of urinary incontinence

AK Nambiar, R Bosch, F Cruz, GE Lemack… - European urology, 2018 - Elsevier
Abstract Context The European Association of Urology guidelines on urinary incontinence
(UI) have been updated in cyclical fashion with successive major chapters being revised …

Which anticholinergic drug for overactive bladder symptoms in adults

P Madhuvrata, JD Cody, G Ellis… - Cochrane Database …, 2012 - cochranelibrary.com
Which anticholinergic drug for overactive bladder symptoms in adults - Madhuvrata, P - 2012 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Current and emerging pharmacological targets and treatments of urinary incontinence and related disorders

MC Michel, L Cardozo, CJ Chermansky, F Cruz… - Pharmacological …, 2023 - ASPET
Overactive bladder syndrome with and without urinary incontinence and related conditions,
signs, and disorders such as detrusor overactivity, neurogenic lower urinary tract …

Screening Tool for Older Persons' Appropriate Prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment …

T Kojima, K Mizukami, N Tomita, H Arai… - Geriatrics & …, 2016 - Wiley Online Library
Abstract Aim In 2005, the Japan Geriatrics Society published a list of potentially
inappropriate medication that was an extract from the “Guidelines for medical treatment and …

Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses

N Buser, S Ivic, TM Kessler, AGH Kessels… - European urology, 2012 - Elsevier
CONTEXT: Millions of people worldwide experience overactive bladder (OAB), and
antimuscarinics are the pharmacologic treatment of choice. Several conventional meta …

Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis

L Chen, SEL Staubli, MP Schneider, AG Kessels, S Ivic… - European urology, 2015 - Elsevier
Context Erectile dysfunction (ED) is a major health care problem worldwide and
phosphodiesterase 5 inhibitors (PDE5Is) are the pharmacological treatment of choice …

Phase III, randomised, double‐blind, placebo‐controlled study of the β3‐adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive …

O Yamaguchi, E Marui, H Kakizaki, Y Homma… - BJU …, 2014 - Wiley Online Library
Objective To evaluate the efficacy and safety of the β3‐adrenoceptor agonist mirabegron, in
a J apanese population with overactive bladder (OAB). Patients and Methods This …

[HTML][HTML] CUA guideline on adult overactive bladder

J Corcos, M Przydacz, L Campeau… - Canadian Urological …, 2017 - ncbi.nlm.nih.gov
The. overactive. bladder.(OAB). picture. has. dramatically. changed. in. the. last. 20. years..
A. quarter. century. ago,. this. symptom. complex. did. not. even. exist.. Bladder. hyperactivity …